Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Proteins ; 91(6): 750-770, 2023 06.
Article in English | MEDLINE | ID: mdl-36607613

ABSTRACT

Lignocellulose is the most abundant natural biopolymer on earth and a potential raw material for the production of fuels and chemicals. However, only some organisms such as bacteria and fungi produce enzymes that metabolize this polymer. In this work we have demonstrated the presence of cellulolytic activity in the supernatant of Scenedesmus quadricauda cultures and we identified the presence of extracellular cellulases in the genome of five Scenedesmus species. Scenedesmus is a green alga which grows in both freshwater and saltwater regions as well as in soils, showing highly flexible metabolic properties. Sequence comparison of the different identified cellulases with hydrolytic enzymes from other organisms using multisequence alignments and phylogenetic trees showed that these proteins belong to the families of glycosyl hydrolases 1, 5, 9, and 10. In addition, most of the Scenedesmus cellulases showed greater sequence similarity with those from invertebrates, fungi, bacteria, and other microalgae than with the plant homologs. Furthermore, the data obtained from the three dimensional structure showed that both, their global structure and the main amino acid residues involved in catalysis and substrate binding are well conserved. Based on our results, we propose that different species of Scenedesmus could act as biocatalysts for the hydrolysis of cellulosic biomass produced from sunlight.


Subject(s)
Cellulases , Scenedesmus , Scenedesmus/metabolism , Phylogeny , Cellulases/genetics , Cellulases/metabolism , Bacteria/metabolism , Hydrolysis , Fungi/metabolism
2.
Plant Mol Biol ; 108(4-5): 363-378, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34546521

ABSTRACT

Ostreococcus tauri is a picoalga that contains a small and compact genome, which resembles that of higher plants in the multiplicity of enzymes involved in starch synthesis (ADP-glucose pyrophosphorylase, ADPGlc PPase; granule bound starch synthase, GBSS; starch synthases, SSI, SSII, SSIII; and starch branching enzyme, SBE, between others), except starch synthase IV (SSIV). Although its genome is fully sequenced, there are still many genes and proteins to which no function was assigned. Here, we identify the OT_ostta06g01880 gene that encodes CBM20CP, a plastidial protein which contains a central carbohydrate binding domain of the CBM20 family, and a coiled coil domain at the C-terminus that lacks catalytic activity. We demonstrate that CBM20CP has the ability to bind starch, amylose and amylopectin with different affinities. Furthermore, this protein interacts with OsttaSSIII-B, increasing its binding to starch granules, its catalytic efficiency and promoting granule growth. The results allow us to postulate a functional role for CBM20CP in starch metabolism in green algae. KEY MESSAGE: CBM20CP, a plastidial protein that has a modular structure but lacks catalytic activity, regulates the synthesis of starch in Ostreococcus tauri.


Subject(s)
Algal Proteins/metabolism , Chlorophyta/metabolism , Starch/metabolism , Algal Proteins/genetics , Amino Acid Sequence , Amylopectin/metabolism , Amylose/metabolism , Chlorophyta/enzymology , Chlorophyta/genetics , Cloning, Molecular , Plastids , Protein Binding , Sequence Alignment
3.
J Reprod Med ; 48(10): 818-20, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14619651

ABSTRACT

OBJECTIVE: To describe reported medication errors in the obstetric inpatients in 1 hospital. STUDY DESIGN: We analyzed all errors, reported voluntarily in a nonpunitive manner, from December 1996 to November 2001. RESULTS: The 164 medication errors led to 154 class 1 (no harm), 10 class 2 (additional therapy but no additional harm) and 0 class 3 (permanent harm) adverse drug events. Omissions and incorrect timing of drug administration were the most common reasons. The rate of class 1 adverse drug events was lower in labor and delivery than on the ward (0.8 versus 1.4 per 1,000 patient days; P < .05). Excess dosing with intravenous magnesium sulfate was the most common class 2 event. CONCLUSION: Reported medication errors on 1 inpatient obstetric service were very rare and not associated with permanent harm. Reporting these errors may identify system improvements and avoid recurrences.


Subject(s)
Hospitalization , Medication Errors/statistics & numerical data , Obstetrics and Gynecology Department, Hospital/standards , Pharmacy Service, Hospital/standards , Quality Assurance, Health Care , Female , Hospitals, University , Humans , New Mexico/epidemiology , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...